The purpose of the company is to advise pharmaceutical companies, research institutions, academic entities, and service providers in the fields of research, preclinical and clinical development, production, and market launch of radiopharmaceuticals. This includes, in particular, the evaluation of research programs, the analysis of product pipelines, and the integration of new technologies. The company may participate in other ventures, as well as acquire, utilize, manage, and dispose of real estate and intellectual property rights. It may establish subsidiaries and branches both domestically and abroad, and may also perform all legal actions that the company's purpose may entail or that are suitable to promote its development or that of group companies. The company may grant direct or indirect financing to third parties, including companies in which it is directly or indirectly involved, its direct or indirect shareholders, and companies in which these shareholders are directly or indirectly involved, either through loans or other forms of financing. It may also provide securities of any kind for their liabilities, including pledges on or fiduciary transfers of the company's assets, or guarantees of any kind, whether for compensation or not.
Outbound Leads by COHAGA